Continue your cat’s existing treatment
Do not stop or change prescribed medications or a prescription diet on your own to take part in the study. Tell us about your cat’s current treatment when you apply.
GCR-002 Feline Kidney Health Study
Recruiting 60 cats · Healthy cats and cats with CKD at IRIS stages 1–3
Participating Cats
As of
Study supplement code: GCR-002
Apply for Your CatThis study takes place in South Korea. Future studies may offer participation opportunities in more countries and regions.
Our research team will review your application and contact you about whether your cat is eligible.

Healthy cats and cats with CKD at IRIS stages 1–3
Whole capsules, twice daily
In person, in South Korea
STUDY PRINCIPLES
Do not stop or change prescribed medications or a prescription diet on your own to take part in the study. Tell us about your cat’s current treatment when you apply.
Our research team reviews your cat’s health, current treatment, and ability to take whole capsules to determine whether participation is appropriate.
Your cat’s health and comfort come first throughout the study. If your cat needs veterinary care, that care takes priority over the study schedule or supplementation.
GCR-002 is the product code for the supplement being evaluated in this study.
The formulation is based on key ingredients that TT, a cat with stage 2 CKD, has received over many years. This study compares test results before and after 28 days of supplementation.
One cat’s experience cannot establish whether a supplement or a particular ingredient is effective. This study examines changes in health markers before and after GCR-002 supplementation.
Recent footage of TT, a cat with stage 2 CKD, running around at home (2026)
WHAT WE MEASURE
We compare blood test results before and after 28 days of GCR-002 supplementation. We examine markers related to kidney and liver health, as well as gene expression related to inflammation and metabolism.
Creatinine (CRE), blood urea nitrogen (BUN), SDMA, phosphorus (PHOS), and other markers.
ALT, ALP, total bilirubin (TBIL), and other markers.
Gene expression related to inflammation and metabolism, including IL1B, TNF, and SIRT1.
Blood-type-related genetic information and information across 10 health categories, including AIM (CD5L) exon 3 analysis.
Genetic test results do not provide a definitive diagnosis or guarantee future health outcomes.
CKD means chronic kidney disease. IRIS stages are part of the International Renal Interest Society system that veterinarians use to assess CKD.
Current kidney test results may provide a reference for tracking future changes in health.
Current kidney test results may help inform comparisons before and after the study and discussions about future care.
We assess current kidney health and compare key test results before and after 28 days of supplementation.
We carefully review current health, prescribed medications, prescription diets, and other treatment to determine whether participation is appropriate.
On days 1–28, give GCR-002 as whole capsules twice daily. Do not open the capsules or mix their contents into food.
Attend two in-person visits at a designated participating veterinary clinic in South Korea: baseline testing on day 0 and final testing on day 29 or a later date arranged with the research team.
Keep a daily supplementation record for 28 days and complete a brief health questionnaire twice a week. Report appetite, activity, vomiting, diarrhea, and any other changes. If your cat’s condition changes, contact the research team and your veterinary clinic without waiting for the next questionnaire.
FROM APPLICATION TO COMPLETION
Supplementation for 28 days
Two clinic visits in South Korea
Complete the online application.
Our team reviews your cat’s health, current treatment, and ability to take whole capsules.
Review the study information and give your consent for your cat to participate.
Your cat has a physical examination and baseline blood tests, and you receive GCR-002.
Give the supplement twice daily, keep a daily supplementation record, and complete a health questionnaire twice a week.
Visit the clinic on day 29 or a later date arranged with the research team for final blood tests and genetic testing.
If the final examination is delayed, contact the research team. Your veterinarian and the research team will advise whether supplementation should continue and when it should end. Do not extend the study period on your own.
Receive an individual results report and the post-study support described below.
TESTS AND SUPPORT
The tests included in the study and the GCR-002 supplied for the study are provided at no charge. Separate terms apply to supplement vouchers provided after study completion.
GCR-002 and personalized supplement support
Selected cats receive a one-month supply of GCR-002. After study completion: Vouchers for 11 months of personalized supplement support are provided, subject to the stated voucher terms.
Day 0 and the final visit
Testing includes kidney and liver health markers and whole-blood mRNA analysis.
Blood-type-related information and 10 health categories
Includes AIM (CD5L) exon 3 analysis.
A personalized report and guidance on your cat’s care, based on blood and genetic test results analyzed and interpreted by specialists.
Our research team will review your application and contact you about whether your cat is eligible.
Blood is collected at two visits: on day 0 and at the final examination. A veterinarian checks your cat’s condition, and collection is performed in a way similar to routine blood testing.
For genetic testing, cells are collected with a swab of the inside of your cat’s cheek.
Your cat’s condition and stress level are taken into account throughout all procedures.

PhD in Biological Sciences, KAIST

Professor Emeritus, Nippon Veterinary and Life Science University

Director, Seijo Kobayashi Animal Hospital
Your clinic and appointment schedule will be arranged individually after participation is confirmed.
FAQ
Have a question about the study? Contact our research team.
Contact the Research TeamYes. Do not stop or change your cat’s existing treatment on your own to take part in the study. Tell us about all prescribed medications and prescription diets when you apply.
Please list all supplements your cat currently receives. We will review whether they could affect the study results and provide individual guidance.
No. To keep study conditions consistent, capsules must be given whole. Do not open them or mix their contents into food.
Do not give a double dose on your own. Let the research team know.
Do not give another dose on your own. Tell the research team so they can review your cat’s condition and what happened before advising you.
Yes. Each cat will be assessed individually for eligibility. If more than one cat participates, you must be able to keep separate supplementation and health records for each cat.
Tell the research team if you notice changes in your cat’s usual condition, such as appetite or activity. Do not wait for the next health questionnaire. If you think your cat needs veterinary care, prioritize a veterinary visit over the study schedule.
Future studies may offer opportunities for cats and their families in additional countries and regions. Eligibility and locations will depend on each study’s design and local research arrangements. The current study involves two in-person visits to participating veterinary clinics in South Korea.
If you are interested in future studies, we would be glad to hear from you at program@greycoatresearch.com.
THE CURRENT GCR-002 STUDY
Applications are welcome for healthy cats and cats with CKD at IRIS stages 1–3. Our research team will review your cat’s health, current treatment, and participation requirements before advising you about eligibility.
The current study takes place at participating veterinary clinics in South Korea and requires two in-person visits.
Healthy cats and IRIS stages 1–3 · 60 cats
Apply for Your CatOur research team will review your application and contact you about whether your cat is eligible.
Cats are selected based on study criteria,
not the order in which applications are received.
Contact
program@greycoatresearch.comFUTURE RESEARCH
Following our research from outside South Korea? Future studies may include a broader range of cats and locations. Participation requirements will depend on each study’s design and research arrangements.
For questions or to share your interest in future studies, contact program@greycoatresearch.com.
Contact the Research Team